ZWJ Investment Counsel Inc. Acquires Shares of 2,791 Prestige Consumer Healthcare Inc. (NYSE:PBH)

ZWJ Investment Counsel Inc. acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 2,791 shares of the company’s stock, valued at approximately $201,000.

Other large investors have also recently added to or reduced their stakes in the company. Opal Wealth Advisors LLC acquired a new position in shares of Prestige Consumer Healthcare during the 2nd quarter worth $26,000. Quest Partners LLC increased its stake in shares of Prestige Consumer Healthcare by 2,826.7% during the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock worth $30,000 after purchasing an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after purchasing an additional 208 shares during the last quarter. Gladius Capital Management LP acquired a new position in Prestige Consumer Healthcare in the 2nd quarter valued at $35,000. Finally, Northwestern Mutual Wealth Management Co. grew its stake in Prestige Consumer Healthcare by 562.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after buying an additional 433 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

PBH has been the topic of a number of research analyst reports. DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock opened at $72.30 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $75.80. The firm has a fifty day moving average price of $71.22 and a two-hundred day moving average price of $69.28. The company has a market cap of $3.59 billion, a PE ratio of 17.34, a price-to-earnings-growth ratio of 1.93 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The firm had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. During the same period in the prior year, the firm earned $1.06 EPS. The business’s revenue was down 4.4% on a year-over-year basis. Analysts expect that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.